Home › Funds › Casdin Capital › PSNL

Casdin Capital position in PSNL

PERSONALIS INC · Health Care

Casdin Capital reported holding 2,300,000 shares of PSNL (PERSONALIS INC) in its Q3 2026 13F filing — a position valued at US$37.4M, representing 1.64% of its reported portfolio and ranking #11 among its reported holdings. Casdin Capital has disclosed PSNL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)2.30M sh
Reported value held$37.44M
Portfolio Weight1.64%
First reportedQ1 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Casdin Capital's PSNL position evolved

Casdin Capital first disclosed a stake in PSNL in Q1 2026 at 1,600,000 shares (US$10.2M). The position peaked in Q3 2026 at 2,300,000 shares, worth US$37.4M. Across 3 filings, Casdin Capital increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,300,000 shares valued at US$37.4M — a reduction of -250,000 shares quarter over quarter.. Notable position changes include a 59% increase in Q2 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.60M $10.19M New
Q2 2026 2.55M $34.17M Add
Q3 2026 2.30M $37.44M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PSNL and 13F data

PSNL (PERSONALIS INC) is a Health Care company. 67 other funds we track also report a position in PSNL — the largest reported positions include Merck & Co., Inc. (US$228.7M), ARK Invest (US$115.9M), Lightspeed Management Company, L.L.C. (US$99.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PSNL

All PSNL fund holders →

FAQ

How long has Casdin Capital held PSNL?

Casdin Capital has disclosed PSNL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Casdin Capital's current position in PSNL?

As of Q3 2026, Casdin Capital holds 2.30M shares of PSNL (PERSONALIS INC), valued at $37.44M, representing 1.64% of its reported portfolio and ranking #11.

Has Casdin Capital been buying or selling PSNL?

In the latest 13F filing (Q3 2026), Casdin Capital reduced its position in PSNL. The position peaked in Q3 2026 at 2.30M shares.

Which other funds hold PSNL?

Other major institutional holders of PSNL include Merck & Co., Inc., ARK Invest, Lightspeed Management Company, L.L.C., among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.